THE ROLE OF DENDRITIC CELLS IN FORMATION OF ANTITUMORAL IMMUNITY (literature review)
https://doi.org/10.51523/2708-6011.2014-11-4-3
Abstract
At present, dendritic cells are thought to be the main «professional» antigenpresenting cells. They play the leading role in the triggering of the adaptive immune response and its integration with inborn immunity. These properties of dendritic cells determine significant interest for their possible use as a base for making antitumoral vaccines. The results of the study testify about the amplification of the lymphocytes antitumoral activity in relation to the types of tumors against which DC-vaccination was carried out.
About the Authors
A. I. Kozlova
Gomel State Medical University
Belarus
Belarus
E. V. Voropayev
Gomel State Medical University
Belarus
Belarus
A. I. Konoplya
Kursk State Medical University, Russia
Belarus
Belarus
References
1. Sabado, R. L. Directing dendritic cell immunotherapy towards successful cancer treatment / R. L. Sabado, N. Bhardwaj // Immunotherapy. - 2010. - № 2(1). - P. 37-56.
2. Ахматова, Н. К. Врожденный иммунитет: противоопухолевый и противоинфекционный / Н. К. Ахматова, М. В. Киселевский. - М.: Практическая медицина, 2008. - С. 156-161.
3. Boudreau, J. E. Engineering dendritic cells to enhance cancer immunotherapy / J. E. Boudreau, A. Bonehill, K. Thielemans // Molecular Therapy. - 2011. - Vol. 5, № 5. - P. 841-853.
4. Turnis, M. E. Enhancement of dendritic cell as vaccines for cancer / M. E. Turnis, C. M. Rooney // Immunotherapy. - 2010. - № 2(6). - P. 847-862.
5. Palucka, K. Dendritic cell-based cancer therapeutic vaccines / K. Palucka, J. Banchereau // Immunity. - 2013. - Vol. 39(1). - P. 38-48.
6. Demoulin, S. Tumor microenvironment converts plasmacytoid dendritic cells into immunosuppressive/tolerogenic cells: insight into the molecular mechanisms / S. Demoulin, M. Herfs, P. Delvenne // J. Leukoc. Biol. - 2013. - Vol. 93(3). - P. 343-352.
7. Delamarre, L. Dendritic cell-targeted vaccines / L. Delamarre, L. Cohn // Frontiers in Immunology. - 2014. - № 5. - P. 255-260.
8. Kastenmüller, W. Dendritic cell-targeted vaccines - hope or hype? / W. Kastenmüller, K. Kastenmüller, C. Kurts // Horm. Metab. Res. - 2008. - № 40(2). - P. 75-81.
9. Targeting human dendritic cells subsets for improved vaccines / Hideki Ueno [et al.] // Semin. Immunol. - 2012. - Vol. 23(1). - P. 21-27.
10. Montfoort, N. Understanding MHC class I presentation of viral antigens by human dendritic cells as a basis for rational design of therapeutic vaccines / N. Montfoort, E. Van der Aa, A. Woltman // Front. In Immunol. - 2014. - Vol. 5. - P. 182-185.
11. Helper activity of NK-cells during dendritic cell-mediated induction of melanoma-specific cytotoxic T-cells / J. L. Wong [et al.] // J. Immunotherapy. - 2011. - Vol. 34(3). - P. 270-278.
12. Hanke, N. Dendritic cell tumor killing activity and its potential applications in cancer immunotherapy / N. Henke, D. Alizadeh, E. Katsanis // Crit. Rev. Immunol. - 2013. - Vol. 33(1). - P. 1-21.
13. Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages and dendritic cells enhances tumor-induced immune suppression / S. Ostrand-Rosenberg [et al.] // Semin. Cancer Biol. - 2012. - Vol. 22(4). - P. 275-281.
14. Медяник, И. А. Использование дендритных клеток в иммунотерапии злокачественных опухолей головного мозга / И. А. Медяник, А. П. Фраерман // Украинский нейрохирургический журнал. - 2004. - № 3. - С. 21-23.
15. Kalinski, P. Dendritic cell in immunotherapy of established cancer: roles of signals 1, 2, 3 and 4 / P. Kalinski // Curr. Opin. Investig. Drugs. - 2009. - Vol. 10(6). - P. 526-535.
Review
For citations:
Kozlova A.I., Voropayev E.V., Konoplya A.I. THE ROLE OF DENDRITIC CELLS IN FORMATION OF ANTITUMORAL IMMUNITY (literature review). Health and Ecology Issues. 2014;(4):19-24. (In Russ.) https://doi.org/10.51523/2708-6011.2014-11-4-3
Views: 359
Email this article 